Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL
Public ClinicalTrials.gov record NCT02361346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and tolerability of MT-3724 in subjects with relapsed or refractory B-Cell NHL or relapsed and refractory CLL (Part 1 only) and relapsed and refractory DLBCL (Part 2 and Part 3). Part 3 evaluates the efficacy of MT-3724.
Study identification
- NCT ID
- NCT02361346
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 38 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2015 (Actual)
- Primary completion
- Mar 22, 2021 (Actual)
- Completion
- Mar 22, 2021 (Actual)
- Last update posted
- Aug 18, 2022
2015 – 2021
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724 | — |
| Innovative Clinical Research Institute, LLC | Whittier | California | 90602 | — |
| 21st Century Oncology - Jacksonville | Jacksonville | Florida | 32204 | — |
| Orlando Health, Inc. | Orlando | Florida | 32806 | — |
| Orlando Health, Inc. | Orlando | Florida | — | — |
| BRCR Medical Center | Plantation | Florida | 33322 | — |
| ASCLEPES Research Centers | Weeki Wachee | Florida | 34607 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| University of Illinois, Cancer Center | Chicago | Illinois | 60612 | — |
| Healthcare Research Network III, LLC | Tinley Park | Illinois | — | — |
| Carle Foundation Hospital | Urbana | Illinois | — | — |
| Norton Healthcare, Inc | Louisville | Kentucky | — | — |
| New York University Langone Medical Center | New York | New York | 10016 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| UT Health San Antonio Cancer | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02361346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02361346 live on ClinicalTrials.gov.